Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Studies have shown that IFN--inducible protein 10 (CXCL10) exerts hepatoprotective effects in AILI by inducing CXCR2 upregulation in hepatocytes [235]
Those who cannot receive treatment People currently undergoing treatment for diabetes People who have a history of cancer or who are currently undergoing treatment Pregnant women, those who are pregnant or breastfeeding, those who are within 3 months after giving birth, and those who are planning to become pregnant Under the age of 18 and over the age of 60 Those who are extremely thin People with eating disorders (anorexia or bulimia) People with thyroid disease or pancreatic disease FAQ When does the effect appear
The FDA does not verify the safety, quality, or effectiveness of compounded drugs
Understanding proper storage is essential for patients to ensure optimal therapeutic outcomes
Muscle mass plays a major role in metabolic rate, and metabolic rate strongly influences long-term weight stability
US$ 27.06
US$ 26.56
US$ 22.27
US$ 26.32
